Sodium intake and blood pressure in renal transplant recipients

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3352-3359

  Van Den Berg, Else ^a,b   Geleijnse, Johanna M ^a   Brink, Elizabeth J ^c,d   Van Baak, Marleen A ^a,e   Homan Van Der Heide, Jaap J ^b   Gans, Rijk O B ^b   Navis, Gerjan ^b   Bakker, Stephan J L ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d TNO   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

blood pressure; renal transplantation; sodium intake

Indexed keywords

CREATININE; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SODIUM INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ADULT; AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIET, SODIUM-RESTRICTED; FEMALE; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; SODIUM; SODIUM, DIETARY;

EID: 84864627402     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs069     Document Type: Article

References (49)

1. Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
2. Kasiske BL. Cardiovascular disease after renal transplantation. Semin Nephrol 2000; 20: 176-187.
3. Aakhus S, Dahl K, Wideroe TE. Cardiovascular disease in stable renal transplant patients in Norway: Morbidity and mortality during a 5-yr follow-up. Clin Transplant 2004; 18: 596-604.
4. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998; 53: 217-222.
5. Kasiske BL, Anjum S, Shah R et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071-1081.
6. Strazzullo P, D'Elia L, Kandala NB et al. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009; 339: b4567.
7. Allison DB, Fontaine KR, Manson JE et al. Annual deaths attributable to obesity in the United States. JAMA 1999; 282: 1530-1538.
8. Gregg EW, Cheng YJ, Cadwell BL et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005; 293: 1868-1874.
9. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005; 111: 2684-2698.
10. Weir MR, Fink JC. Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. Am J Kidney Dis 2005; 45: 176-188.
11. Swift PA, Markandu ND, Sagnella GA et al. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005; 46: 308-312.
12. Moeller T, Buhl M, Schorr U et al. Salt intake and hypertension in renal transplant patients. Clin Nephrol 2000; 53: 159-163.
13. Prasad GV, Huang M, Nash MM et al. Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. Transplant Proc 2005; 37: 1896-1897.
14. Kalbfleisch JH, Hebert LA, Lemann J, Jr et al. Habitual excessive dietary salt intake and blood pressure levels in renal transplant recipients. Am J Med 1982; 73: 205-210.
15. Ramesh Prasad GV, Huang M, Nash MM et al. The role of dietary cations in the blood pressure of renal transplant recipients. Clin Transplant 2006; 20: 37-42.
16. Kidney Disease Outcomes Quality Initiative (K/DOQI)K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43 (5 Suppl 1): S1-290.
17. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.
18. Centers for Disease Control and Prevention (CDC)Application of lower sodium intake recommendations to adults-United States, 1999-2006. MMWR Morb Mortal Wkly Rep 2009; 58: 281-283.
19. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans. 2010. (1 January 2012, date last accessed)..
20. Du Bois D, Du Bois EF. Clinical calorimetry. Tenth paper. A formula to estimate the approximate surface area if height and weight be known. Arch Int Med 1916; 17: 863-871.
21. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297: 319-328.
22. Frost CD, Law MR, Wald NJ. By how much does dietary salt reduction lower blood pressure? II-analysis of observational data within populations. BMJ 1991; 302: 815-818.
23. Ix JH, Wassel CL, Stevens LA et al. Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. Clin J Am Soc Nephrol 2011; 6: 184-191.
24. Navis G, de Jong PE, Donker AJ et al. Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition. Kidney Int 1987; 31: 815-819.
25. Slagman MC, Waanders F, Hemmelder MH et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ 2011; 343: d4366.
26. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
27. Pinto-Sietsma SJ, Janssen WM, Hillege HL et al. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 2000; 11: 1882-1888.
28. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 2009; 27: 280-286.
29. Gauer OH, Kreislauf des Blutes In: Landois L, Rosemann H-U Lehrbuch der Physiologie des Menschen Berlin, Germany: Von Urban and Schwarzenberg, 1960, pp. 95-135.
30. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603-611.
31. Young JB, Neumayer HH, Gordon RD. Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk. Kidney Int Suppl 2010: S1-S7.
32. Krikken JA, Laverman GD, Navis G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens 2009; 18: 531-538.
33. van Zuilen AD, Blankestijn PJ, van Buren M et al. Quality of care in patients with chronic kidney disease is determined by hospital specific factors. Nephrol Dial Transplant 2010; 25: 3647-3654.
34. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153: 598-615.
35. Cook NR, Cutler JA, Obarzanek E et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885-888.
36. Vegter S, Perna A, Postma MJ et al. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 2012; 23: 165-173.
37. Lambers Heerspink HJ, Holtkamp FA, Parving HH et al. Moderate sodium diet potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers: a post-hoc analysis of the RENAAL and IDNT trials. Kidney Int 2012; doi:10.1038/ki.2012.74.
38. Vogt L, Waanders F, Boomsma F et al. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 2008; 19: 999-1007.
39. Koomans HA, Roos JC, Boer P et al. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension 1982; 4: 190-197.
40. Navis G, de Jong P, Donker AJ et al. Diuretic effects of angiotensinconverting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients. J Cardiovasc Pharmacol 1987; 9: 743-748.
41. Rocchini AP. Obesity hypertension. Am J Hypertens 2002; 15: 50S-52S.
42. Rocchini AP. Obesity hypertension, salt sensitivity and insulin resistance. Nutr Metab Cardiovasc Dis 2000; 10: 287-294.
43. First MR, Neylan JF, Rocher LL et al. Hypertension after renal transplantation. J Am Soc Nephrol 1994; 4 (Suppl 8): S30-S36.
44. Van Buren DH, Burke JF, Lewis RM. Renal function in patients receiving long-term cyclosporine therapy. J Am Soc Nephrol 1994; 4 (Suppl 8): S17-S22.
45. Sander M, Lyson T, Thomas GD et al. Sympathetic neural mechanisms of cyclosporine-induced hypertension. Am J Hypertens 1996; 9: 121S-138S.
46. Koomans HA, Ligtenberg G. Mechanisms and consequences of arterial hypertension after renal transplantation. Transplantation 2001; 72 (Suppl 6): S9-S12.
47. Guyton AC, Hall JE. Functional organization of the human body and control of the "internal environment". In: Guyton AC, Hall JE. Textbook of Medical Physiology 9th edn. Philadelphia, PA: Saunders, 1996.
48. Guyton AC, Hall JE. Regulation of extracellular fluid osmolarity and sodium concentration. In: Guyton AC, Hall JE. Textbook of Medical Physiology. 9th edn. Philadelphia, PA: Saunders, 1996: 349.
49. Zoungas S, Kerr PG, Chadban S et al. Arterial function after successful renal transplantation. Kidney Int 2004; 65: 1882-1889